Compounds > 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane
Page last updated: 2024-09-05

1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and ibutilide

1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane has been researched along with ibutilide in 1 studies

Compound Research Comparison

Studies
(1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane)		Trials
(1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane)		Recent Studies (post-2010)
(1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane)		Studies
(ibutilide)		Trials
(ibutilide)		Recent Studies (post-2010) (ibutilide)
36192805847

Protein Interaction Comparison

ProteinTaxonomy1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane (IC50)ibutilide (IC50)
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.013

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD1

Other Studies

1 other study(ies) available for 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and ibutilide

ArticleYear
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
    Bioorganic & medicinal chemistry letters, 2004, Sep-20, Volume: 14, Issue:18

    Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2004